In the phase 3 SUBITO trial, researchers aimed to compare outcomes with intensified alkylating chemotherapy to those with an HRD-targeting regimen.

Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.

Each additional hour per day of prolonged sedentary behavior is associated with a higher hazard of cancer death ...

ASCO's 2026 annual conference in Chicago featured cutting-edge research on treatment strategies for sarcomas such as GIST and ...

Investigators conducted a retrospective analysis to determine whether postmenopausal women with a history of breast cancer can safely receive vaginal estrogen.

Investigators compared trial demographics against baseline electronic health record data at 3 NCI–designated cancer centers to identify enrollment gaps.

In this study, researchers aimed to evaluate patterns of engagement with health-related content on social media among US adults both with and without chronic conditions.

The US Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer ...

In this phase 3 trial, researchers aimed to characterize the clinical characteristics, treatment approaches, and outcomes of patients with metastatic non-rhabdomyosarcoma soft tissue sarcoma and to ...

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

This report presents the long-term follow-up results of JCOG1008, phase 2/3 trial comparing weekly cisplatin versus 3-weekly cisplatin for patients with postoperative high-risk locally advanced ...

This study evaluated the demographic and clinicopathologic characteristics of early-onset breast cancer among young Black women to determine the prevalence of hereditary breast cancer germline ...